High-level anxiety is associated with worse clinical symptoms and aberrant brain networks in Parkinson's disease
Chen, Z.; Li, G.; Zhou, L.; Zhang, L.; Liu, J.
Show abstract
BackgroundAnxiety is one of the most common psychiatric symptoms in Parkinsons disease (PD). Whether anxiety shapes disease progression and brain network aberrations in PD remain largely unknown. The objective of present study is to investigate whether anxiety exacerbates clinical symptoms and brain network abnormalities of PD patients. MethodsPD patients performing magnetic resonance imaging from Parkinsons Progression Markers Initiative (PPMI) database were specifically included. According to the scores of State-Trait Anxiety Inventory (STAI), PD patients were classified into lower quartile group (STAI score rank: 0%[~]25%), interquartile group (STAI score rank: 26%[~]75%), and upper quartile group (STAI score rank: 76%[~]100%) based on their STAI score quartiles to investigate how anxiety affects clinical manifestations and brain networks. ResultsAnxiety was independently associated with both motor and non-motor symptoms of PD patients. Consistently, PD patients in the upper quartile group showed more severe non-motor symptoms compared to lower quartile group. Moreover, they also exhibited significantly different topological metrics in structural network compared to lower quartile group. Furthermore, we demonstrated that differential network metrics mediated the associations between anxiety and motor and non-motor symptoms of PD patients. ConclusionsPD patients with higher anxiety level exhibited more severe clinical manifestations and disruptions of brain network topology. Diverse structural network metrics were associated with motor and non-motor symptoms of PD patients.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Microstructure predicts non-motor outcomes following Deep Brain Stimulation in Parkinson’s disease 95%
- Nigral volume loss in prodromal, early, and moderate Parkinson’s disease 94%
- Repurposing the Memory-promoting Meclofenoxate Hydrochloride as a Treatment for Parkinson's Disease through Integrative Multi-omics analysis 94%
Similar papers in this journal
- Nigral pathology contributes to microstructural integrity of striatal and frontal tracts in Parkinson's disease 95%
- Decoupling of global brain activity and cerebrospinal fluid flow in Parkinson's cognitive decline 94%
- Distinct Longitudinal Clinical-Neuroanatomical Trajectories in Parkinson’s Disease Clinical Subtypes: Insight Towards Precision Medicine 94%
Similar papers in this journal
- Disrupted topological properties of structural brain networks presents a glutamatergic neuropathophysiology in narcolepsy patients 94%
- EEG-based Machine Learning Models for the Prediction of Phenoconversion Time and Subtype in iRBD 94%
- Phase and amplitude correlations change with disease progression in idiopathic Rapid eye-movement sleep behavior disorder patients 94%
Similar papers in this journal
- Apathy progression is associated with brain atrophy and white matter damage in Parkinson's disease 95%
- White matter microstructure in Parkinson’s disease with and without elevated REM sleep muscle tone 95%
- Changes in electrophysiological aperiodic activity during cognitive control in Parkinson's disease 94%
Similar papers in this journal
- Neural Oscillatory Characteristics of Feedback Associated Activity in Globus Pallidus Interna 93%
- A novel method to assess motor planning deficits in patients with Parkinson's disease and mild cognitive impairment 92%
- Candidate genes associated with neurological manifestations of COVID-19: Meta-analysis using multiple computational approaches 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.